Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare M Adams

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Nature Communications|February 22, 2020
Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survivalRamkrishna Mitra, Clare M Adams, Wei Jiang, et al.
Molecular & Cellular Oncology|March 12, 2020
Targeting MYC through WDR5Lance R Thomas, Clare M Adams, Stephen W Fesik, et al.
Leukemia|October 23, 2019
Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphomaClare M Adams, Ramkrishna Mitra, Ashley N Vogel, et al.
Molecular Cancer Research : MCR|September 28, 2018
Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and InvasionEvan J Greenawalt, Mick D Edmonds, Neha Jain, et al.
The Journal of Clinical Investigation|January 18, 2017
BCL-W has a fundamental role in B cell survival and lymphomagenesisClare M Adams, Annette S Kim, Ramkrishna Mitra, et al.
The Journal of Investigative Dermatology|December 6, 2013
miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphomaLaura Y McGirt, Clare M Adams, Devin A Baerenwald, et al.
Cancers|June 19, 2024
Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell LymphomaClare M Adams, Amanda McBride, Peter Michener, et al.
Aging Cell|July 24, 2024
DNA fork remodeling proteins, Zranb3 and Smarcal1, are uniquely essential for aging hematopoiesisSaul Kushinsky, Matthew V Puccetti, Clare M Adams, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2019
MicroRNA-21 is Required for Hematopoietic Cell Viability After Radiation ExposureMatthew V Puccetti, Clare M Adams, Tu D Dan, et al.
Cancer Discovery|February 3, 2023
Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast CancerClare M Adams, Ramkrishna Mitra, Youcai Xiao, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature Communications|February 22, 2020
Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survivalRamkrishna Mitra, Clare M Adams, Wei Jiang, et al.
Molecular & Cellular Oncology|March 12, 2020
Targeting MYC through WDR5Lance R Thomas, Clare M Adams, Stephen W Fesik, et al.
Leukemia|October 23, 2019
Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphomaClare M Adams, Ramkrishna Mitra, Ashley N Vogel, et al.
Molecular Cancer Research : MCR|September 28, 2018
Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and InvasionEvan J Greenawalt, Mick D Edmonds, Neha Jain, et al.
The Journal of Clinical Investigation|January 18, 2017
BCL-W has a fundamental role in B cell survival and lymphomagenesisClare M Adams, Annette S Kim, Ramkrishna Mitra, et al.
The Journal of Investigative Dermatology|December 6, 2013
miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphomaLaura Y McGirt, Clare M Adams, Devin A Baerenwald, et al.
Cancers|June 19, 2024
Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell LymphomaClare M Adams, Amanda McBride, Peter Michener, et al.
Aging Cell|July 24, 2024
DNA fork remodeling proteins, Zranb3 and Smarcal1, are uniquely essential for aging hematopoiesisSaul Kushinsky, Matthew V Puccetti, Clare M Adams, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2019
MicroRNA-21 is Required for Hematopoietic Cell Viability After Radiation ExposureMatthew V Puccetti, Clare M Adams, Tu D Dan, et al.
Cancer Discovery|February 3, 2023
Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast CancerClare M Adams, Ramkrishna Mitra, Youcai Xiao, et al.
Pageof 3